230 related articles for article (PubMed ID: 20930307)
1. Enhanced expression of the voltage-dependent anion channel 1 (VDAC1) in Alzheimer's disease transgenic mice: an insight into the pathogenic effects of amyloid-β.
Cuadrado-Tejedor M; Vilariño M; Cabodevilla F; Del Río J; Frechilla D; Pérez-Mediavilla A
J Alzheimers Dis; 2011; 23(2):195-206. PubMed ID: 20930307
[TBL] [Abstract][Full Text] [Related]
2. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
[TBL] [Abstract][Full Text] [Related]
3. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R
Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729
[TBL] [Abstract][Full Text] [Related]
4. The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.
Smilansky A; Dangoor L; Nakdimon I; Ben-Hail D; Mizrachi D; Shoshan-Barmatz V
J Biol Chem; 2015 Dec; 290(52):30670-83. PubMed ID: 26542804
[TBL] [Abstract][Full Text] [Related]
5. VDAC1, mitochondrial dysfunction, and Alzheimer's disease.
Shoshan-Barmatz V; Nahon-Crystal E; Shteinfer-Kuzmine A; Gupta R
Pharmacol Res; 2018 May; 131():87-101. PubMed ID: 29551631
[TBL] [Abstract][Full Text] [Related]
6. Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: implications for synaptic dysfunction and neuronal damage.
Reddy PH
Biochim Biophys Acta; 2013 Dec; 1832(12):1913-21. PubMed ID: 23816568
[TBL] [Abstract][Full Text] [Related]
7. Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?
Reddy PH
Biochim Biophys Acta; 2013 Jan; 1832(1):67-75. PubMed ID: 22995655
[TBL] [Abstract][Full Text] [Related]
8. RNA silencing of genes involved in Alzheimer's disease enhances mitochondrial function and synaptic activity.
Manczak M; Reddy PH
Biochim Biophys Acta; 2013 Dec; 1832(12):2368-78. PubMed ID: 24063855
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.
Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM
J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556
[TBL] [Abstract][Full Text] [Related]
10. Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome.
Yoo BC; Fountoulakis M; Cairns N; Lubec G
Electrophoresis; 2001 Jan; 22(1):172-9. PubMed ID: 11197169
[TBL] [Abstract][Full Text] [Related]
11. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
12. Reduced VDAC1 protects against Alzheimer's disease, mitochondria, and synaptic deficiencies.
Manczak M; Sheiko T; Craigen WJ; Reddy PH
J Alzheimers Dis; 2013; 37(4):679-90. PubMed ID: 23948905
[TBL] [Abstract][Full Text] [Related]
13. Biological and biophysics aspects of metformin-induced effects: cortex mitochondrial dysfunction and promotion of toxic amyloid pre-fibrillar aggregates.
Picone P; Vilasi S; Librizzi F; Contardi M; Nuzzo D; Caruana L; Baldassano S; Amato A; Mulè F; San Biagio PL; Giacomazza D; Di Carlo M
Aging (Albany NY); 2016 Aug; 8(8):1718-34. PubMed ID: 27509335
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of hesperidin against amyloid-β (Aβ) induced neurotoxicity through the voltage dependent anion channel 1 (VDAC1)-mediated mitochondrial apoptotic pathway in PC12 cells.
Wang DM; Li SQ; Zhu XY; Wang Y; Wu WL; Zhang XJ
Neurochem Res; 2013 May; 38(5):1034-44. PubMed ID: 23475456
[TBL] [Abstract][Full Text] [Related]
15. Reduced VDAC1, Maintained Mitochondrial Dynamics and Enhanced Mitochondrial Biogenesis in a Transgenic Tau Mouse Model of Alzheimer's Disease.
Vijayan M; Reddy PH
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955694
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of VDAC1 Rescues A
Zhou X; Tang X; Li T; Li D; Gong Z; Zhang X; Li Y; Zhu J; Wang Y; Zhang B
Mediators Inflamm; 2023; 2023():6739691. PubMed ID: 36816741
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen kringle 5 induces endothelial cell apoptosis by triggering a voltage-dependent anion channel 1 (VDAC1) positive feedback loop.
Li L; Yao YC; Gu XQ; Che D; Ma CQ; Dai ZY; Li C; Zhou T; Cai WB; Yang ZH; Yang X; Gao GQ
J Biol Chem; 2014 Nov; 289(47):32628-38. PubMed ID: 25296756
[TBL] [Abstract][Full Text] [Related]
18. Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathology.
Verma A; Shteinfer-Kuzmine A; Kamenetsky N; Pittala S; Paul A; Nahon Crystal E; Ouro A; Chalifa-Caspi V; Pandey SK; Monsonego A; Vardi N; Knafo S; Shoshan-Barmatz V
Transl Neurodegener; 2022 Dec; 11(1):58. PubMed ID: 36578022
[TBL] [Abstract][Full Text] [Related]
19. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
[TBL] [Abstract][Full Text] [Related]
20. Relationship between expression of voltage-dependent anion channel (VDAC) isoforms and type of hexokinase binding sites on brain mitochondria.
Poleti MD; Tesch AC; Crepaldi CR; Souza GH; Eberlin MN; de Cerqueira César M
J Mol Neurosci; 2010 May; 41(1):48-54. PubMed ID: 19688190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
